Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.
Press releases published on September 28, 2025
The Mortgage Calculator Enhances Bank Statement Loan Program for Self-Employed Homebuyers
New program enhancements allow entrepreneurs and gig economy workers to qualify for home loans using bank statements instead of traditional tax returns. MIAMI, FL, UNITED STATES, September 28, 2025 /EINPresswire.com/ -- The Mortgage Calculator, a …
Beyond Building Profit: RockToken Commits to Public Welfare and Sustainable Blockchain Growth
From Clean Power to Community Care: RockToken Expands Its Mission Beyond Technology AUCKLAND, NEW ZEALAND, September 28, 2025 /EINPresswire.com/ -- Energy consumption, carbon emission, and heat pollution remain a growing concern in blockchain computing. …
South Carolina Buyers Can Book Tours Seamlessly with Houzeo’s ‘Schedule Showing’ Feature
South Carolina buyers can now schedule showings instantly with Houzeo and tour homes on their own time. COLUMBIA, SC, UNITED STATES, September 28, 2025 /EINPresswire.com/ -- Houzeo, America’s best home buying app, has introduced its latest feature—‘ …
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
1. About LEQEMBI (generic name: lecanemab, Chinese brand name: 乐意保) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble …
Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
BALA CYNWYD, Pa., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host a …
ROSEN, A LEADING NATIONAL FIRM, Encourages Fortinet, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTNT
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Fortinet, Inc. (NASDAQ: FTNT) common stock between …
SNPS Investor News: If You Have Suffered Losses in Synopsys, Inc. (NASDAQ: SNPS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Synopsys, Inc. (NASDAQ: SNPS) resulting from allegations that Synopsys …
LINEAGE DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Lineage, Inc. Investors to Secure Counsel Before Important September 30 Deadline in Securities Class Action – LINE
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Lineage, Inc. (NASDAQ: LINE) common stock pursuant and/or traceable to the registration statement issued in connection with Lineage’s …
MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 program using the higher clinical response level of HS Clinical …
ROSEN, A LEADING LAW FIRM, Encourages PubMatic, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PUBM
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PubMatic, Inc. (NASDAQ: PUBM) between February 27, 2025 and August 11, 2025, both dates inclusive (the “Class Period”), …
Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM
- By Month 1, numerically fewer cumulative events were observed with acoramidis compared to placebo - Acoramidis significantly reduced the cumulative risk of CVM or recurrent CVH through Month 30 versus placebo with a 49% hazard reduction (p<0.0001) - The …
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Quantum Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - QMCO
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quantum Corporation (NASDAQ: QMCO) between November 15, 2024 and August 18, 2025, inclusive (the “Class Period”), of …
Silent Strain: New Data Shows Men in Their 40's Facing Unprecedented Mental Health Crisis
New data reveals midlife men face record levels of stress, loneliness, and health risks—sparking urgent calls for mental health solutions SAN DIEGO, CA, UNITED STATES, September 28, 2025 /EINPresswire.com/ -- A CRISIS IN THE SHADOWS Men across …
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 …